Elite Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Two
Elite Pharmaceuticals, Inc. (ELTP) had Long-Term Debt, Maturity, Year Two of $125.00 thousand as of 2022-03-31, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2022-11-14
- 2022-03-31: Long-Term Debt, Maturity, Year Two $125.00K.
- 2021-03-31: Long-Term Debt, Maturity, Year Two $115.00K.
- 2020-03-31: Long-Term Debt, Maturity, Year Two $110.00K.
- 2014-09-30: Long-Term Debt, Maturity, Year Two $169.28K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2022-03-31 | $125.00K 10-Q · filed 2022-11-14 |
| 2021-03-31 | $115.00K 10-K · filed 2021-06-14 |
| 2020-03-31 | $110.00K 10-K · filed 2020-06-29 |
| 2014-09-30 | $169.28K 10-Q · filed 2014-11-14 |
| 2014-03-31 | $210.00K 10-K · filed 2014-06-30 |
| 2013-03-31 | $195.00K 10-K · filed 2013-06-21 |